Prosiectau (71)
Cardiff University Schools involved in this Project
Targeted metabolic inhibition of T-lymphocytes: Directing immunity during human disease (01.10.2016 - 15.11.2018)
- Brancale, Andrea
Targeting CtIP to sensitise cancer cells to DNA-damaging agents (01.11.2016 - 31.03.2018)
- Brancale, Andrea
Targeting natural products to counter the challenge of MRSA (01.10.2014 - 30.09.2017)
- Mcguigan, Christopher
Targeting of interleukin-13 receptor (IL-13R) a2 expressing pancreatic cancer by a novel hybrid lytic peptide drug (01.10.2016 - 15.11.2018)
- Brancale, Andrea
Targeting zinc signalling to prevent cell division in cancer (01.10.2016 - 30.09.2018)
- Taylor, Kathryn
Targetting zinc signalling to prevent cell division in cancer (01.10.2015 - 30.09.2018)
- Taylor, Kathryn
Technology Transfer Workshop (15.03.2017 - 31.12.2017)
- Gumbleton, Mark
Telehealth enabled medicines for care home residents (01.09.2014 - 31.12.2023)
- James, Delyth
Testing a new skin injection device (15.09.2021 - 28.02.2022)
- Birchall, James
Testing a novel chemotherapy delivery system using two dinitrobenzamide mustard prodrugs (01.10.2015 - 30.09.2018)
- Mcguigan, Christopher